Atopic Dermatitis News and Research

RSS

Atopic dermatitis is a long-term skin disease. "Atopic" refers to a tendency to develop allergy conditions. "Dermatitis" means swelling of the skin. Atopic dermatitis is most common in babies and children. But it can happen to anyone. People who live in cities and dry climates may be more likely to get this disease. When children with atopic dermatitis grow older, this problem can improve or go away. But the skin may stay dry and easy to irritate. At other times, atopic dermatitis is a problem in adulthood. You can't "catch" the disease or give it to other people.

Modulating the lipid composition to treat bronchial asthma

Bronchial asthma, a chronic inflammatory disease of the airways that is reversible in certain cases, usually presents with cough, difficulty of breathing, and wheezing.

24 Jan 2023

Study reviews mechanistic data on new methods of allergy prevention and treatment

In a recent article published in Science Translational Medicine, researchers reviewed the cause and the underlying pathophysiology of allergic diseases.

23 Jan 2023

Experts propose solutions to address racial disparities affecting people with allergic conditions

In February 2022, the American College of Allergy, Asthma and Immunology convened experts in atopic dermatitis (AD) and food allergy to examine the issue of racial disparities affecting people with these conditions.

12 Jan 2023

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab-;a novel, patient-tailored monoclonal antibody therapy-;showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

Flavonoids with potential to fight allergies and inflammation

In a recent study published in the Biomedicine & Pharmacotherapy journal, researchers explored the anti-allergic and anti-inflammatory properties of flavonoids.

28 Nov 2022

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

22 Nov 2022

Why we should all eat Kimchi and other Korean fermented foods

A recent study reviews various traditional Korean fermented foods for their various health benefits.

20 Nov 2022

Small molecules found in breast milk may reduce the likelihood of infants developing allergies

Breastfed babies are believed to suffer fewer allergic conditions, like eczema and food allergies, than formula-fed babies; yet the reason has not been well understood.

15 Nov 2022

Practical tips to manage atopic dermatitis in babies

Eczema -; atopic dermatitis -; is common in babies and can be stressful for parents to manage. An article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.212094 outlines practical tips to manage this condition.

7 Nov 2022

Extreme climatic events pose a significant threat to global dermatological health

The skin is a large, complex organ, and it serves as the body's primary interface with the environment, playing key roles in sensory, thermoregulatory, barrier, and immunological functioning.

20 Oct 2022

Does skin inflammation exacerbate COVID-19?

In a new study, researchers discussed inflammation during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Oct 2022

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

A new review discussed the applications of single-cell ribonucleic acid sequencing (scRNA-seq) in understanding autoimmune disorders.

17 Oct 2022

MSU researchers use big data and AI to identify existing drugs to fight new COVID-19 variants

MSU researchers are using big data and AI to identify current drugs that could be applied to treat new COVID-19 variants.

6 Oct 2022

Studies explore how differences in skin composition may lead to dermatological conditions

Why are certain body parts more prone to skin diseases than others? Two new UC Davis Health studies explored how differences in skin composition may lead to dermatological conditions, such as psoriasis and atopic dermatitis.

23 Sep 2022

Itchy eczema in children finally gets relief

This is the first large-scale, randomized, placebo-controlled trial of a monoclonal antibody in any skin disease, including eczema, in children as young as six months. The study, which included 31 sites in Europe and North America, was published in The Lancet.

16 Sep 2022

Study evaluates the effectiveness of teleconsultation for preventing atopic dermatitis in infants

JMIR Publications recently published "Effectiveness of Pediatric Teleconsultation to Prevent Skin Conditions in Infants and Reduce Parenting Stress in Mothers: Randomized Controlled Trial" in JMIR Pediatrics and Parenting which reported that mothers of infants are prone to experiencing parenting stress, which adversely affects mothers' and children's well-being.

2 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

How does obesity affect the immune system?

A new study summarizes new findings on the immunoregulatory effects of excessive fat stores or malnutrition through Th2 cells.

4 Jul 2022

The importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox

Scientists have described the importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox infection.

4 Jul 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

Atopic Dermatitis News and Research

Further Reading

Modulating the lipid composition to treat bronchial asthma

Study reviews mechanistic data on new methods of allergy prevention and treatment

Experts propose solutions to address racial disparities affecting people with allergic conditions

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Flavonoids with potential to fight allergies and inflammation

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

Why we should all eat Kimchi and other Korean fermented foods

Small molecules found in breast milk may reduce the likelihood of infants developing allergies

Practical tips to manage atopic dermatitis in babies

Extreme climatic events pose a significant threat to global dermatological health

Does skin inflammation exacerbate COVID-19?

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

MSU researchers use big data and AI to identify existing drugs to fight new COVID-19 variants

Studies explore how differences in skin composition may lead to dermatological conditions

Itchy eczema in children finally gets relief

Study evaluates the effectiveness of teleconsultation for preventing atopic dermatitis in infants

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

How does obesity affect the immune system?

The importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News